NASDAQ:KYTX | Profit Breakdown | Kyverna Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$39.56M-$38.32M
2026-03-31-$41.37M-$39.73M
2025-12-31-$39.28M-$37.8M
2025-09-30-$38.73M-$36.79M
2025-06-30-$44.41M-$42.08M
2025-03-31-$47.41M-$44.64M
2024-12-31-$41.04M-$37.49M
2024-09-30-$38.77M-$34.49M
2024-06-30-$33.44M-$28.8M
2024-03-31-$29.36M-$26.69M
2023-12-31-$21.38M-$20.67M
2023-09-30-$16.28M-$15.47M
2023-06-30-$13.3M-$13.09M
2023-03-31-$11.45M-$11.14M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$169.83M-$161.31M
2024-12-31-$142.6M-$127.48M
2023-12-31-$62.41M-$60.37M